insights_auto
Why is SCNI down 5.26%?
Dive Deeperchevron_right
SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$1.26
arrow_downward
-5.26%(-0.070) 1D
$1.27
arrow_upward
+0.79% (+0.0100)bedtimeAfter hours
Closed: Oct 5, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$1.33
High
$1.36
Low
$1.26
Mkt. cap
718.23K
Avg. vol.
2.27M
Volume
42.26K
52-wk high
$16.30
52-wk low
$1.26
EPS
-$2.80
Beta
2.13
Shares outstanding
706.59K
No. of employees
45
Open
$1.33
High
$1.36
Low
$1.26
Mkt. cap
718.23K
Avg. vol.
2.27M
Volume
42.26K
52-wk high
$16.30
52-wk low
$1.26
EPS
-$2.80
Beta
2.13
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
The Bond Market Just Sent Investors a Warning. Here's the Mistake I'd Avoid Making With the S&P 500.
TradingView
·
1 hour ago
Dow, S&P 500, Nasdaq Futures Edge Higher After Nasdaq Climbs To Record High: SPCX, USAR, CEG, NVAX Stocks In Focus
AFP.com
·
1 hour ago
Asian stocks mixed despite tech-led Wall St record
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR